Zeit Capital’s Eli Lilly LLY Stock Holding History

Zeit Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$960K	Buy	800 +200	+33%	+$204K	0.58%	18
2026 Q1	$552K	Buy	+600	New	+$608K	0.37%	18

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zeit Capital's LLY Position: Q2 2026 in Review

Zeit Capital increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $204K and bringing the position to 800 shares worth $960K. The position accounts for 0.58% of the portfolio, ranked #18.

Zeit Capital first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Zeit Capital held 800 shares of Eli Lilly worth $960K as of Q2 2026.
Zeit Capital bought 200 Eli Lilly shares in Q2 2026, an estimated $204K.
Eli Lilly made up 0.58% of Zeit Capital's portfolio in Q2 2026, its #18 holding.
Zeit Capital first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Zeit Capital's 13F filing for Q2 2026, filed 6 Aug 2026.